Patient
SITE001-0034
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2025-10-07
Adverse events
3
Serious AEs
0
Open data queries
1
Luna dropout signal
+0.25
Adverse events 3
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-10-13 (study day 183); relationship: not assessed
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-09-20 (study day 160); relationship: NOT RELATED
Grade 1 Alanine aminotransferase increased — outcome: RECOVERED/RESOLVED; onset 2022-06-28 (study day 76); relationship: not assessed
Data queries 1
Temperature 3.7 C is below the plausible minimum 34 C.
Luna engagement
Messages
4
Escalations
0
Check-ins
1
last 2026-09-19
Mood ø
4.0
of 5
Adherence · 7d
0%